Skip to main content
logo
Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
3.760
-0.010 (-0.27%)
At close: Aug 28, 2026, 4:00 PM EDT
3.770
+0.010 (0.27%)
After-hours: Aug 28, 2026, 4:27 PM EDT

Neuphoria Therapeutics Financials Overview

Millions USD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
-0.0115.65--4.170.7
Revenue Growth
----499.60%-66.32%
Gross Profit
-0.0115.65---6.85-3.62
Operating Income
-14.66-0.83-17.8-21.56-12.12-7.7
Net Income
-17.43-0.37-15.49-21.38-14.99-6.52
Earnings Per Share
-4.95-0.23-18.62-0.01-0.01-0.01
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Investments
19.4414.2112.6112.123.1321.37
Total Debt
0.030.150.270.350.480.65
Net Cash (Debt)
19.4114.0612.3411.7522.6520.72
Net Cash Growth
15.02%13.99%4.99%-48.12%9.32%-
Net Cash Per Share
5.518.6614.820.010.020.03

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Cash Flow
-17.150.08-14.68-14.64-14.99-5.65
Capital Expenditures
-----0-0
Free Cash Flow
-17.150.08-14.68-14.64-14.99-5.65
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Gross Margin
-100.00%---164.21%-
Operating Margin
--5.30%---290.62%-1107.29%
Pretax Margin
134183.42%-5.35%---362.51%-957.30%
Profit Margin
--2.36%---359.34%-937.11%
FCF Margin
-0.49%---359.30%-812.46%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
P/FCF Ratio
-172.83----
PS Ratio
-1531.700.85----